12:00 AM
Oct 05, 2009
 |  BC Week In Review  |  Company News  |  Sales & Marketing

CSL, Merck sales and marketing update

Merck received an exclusive license to market CSL's seasonal influenza H1N1 vaccine Afluria in the...

Read the full 65 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >